Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

Retention of golimumab treatment following discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry. Musculoskeletal care. 2021.

28/02/2022

Pombo-Suárez M, Sanchez-Piedra C, Ruiz-Montesino D, Diaz-Torne C, Jovaní V, Cea-Calvo L, et al.

Epub 2021/10/21. doi: 10.1002/msc.1595. PubMed PMID: 34668303.